Natrium Chloratum Physiolog Vantive (Sodium Chloride)

The sodium chloride in the solution dissociates into sodium and chloride ions after infusion. These ions increase plasma osmolality, drawing water into the vascular compartment, expanding extracellular fluid volume, and correcting low sodium or chloride levels that can impair cellular function.

The prescribed dose of Natrium Chloratum Physiolog Vantive is determined by the treating clinician based on the patient’s fluid loss, electrolyte status, body weight, and clinical condition. Healthcare professionals calculate the appropriate volume and infusion rate to achieve the desired therapeutic effect.

Safety data for Natrium Chloratum Physiolog Vantive in pregnancy and lactation are limited. Use should be considered only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natrium Chloratum Physiolog Vantive is a standard isotonic sodium chloride solution similar to other 0.9% NaCl preparations. Differences may lie in manufacturing standards, regulatory approvals, and supply chain reliability. Clinicians choose based on product availability, regulatory compliance, and institutional preferences.

The solution should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect it from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the product, and inspect the vial for any particulate matter before use.

The product is administered intravenously by slow infusion through a calibrated IV set. The infusion rate is set according to the patient’s clinical needs and monitored continuously. Administration should follow aseptic technique and institutional protocols for IV therapy.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and electrolyte‑related cardiac arrhythmias. These events are more likely when the solution is infused too rapidly, in patients with compromised cardiac or renal function, or when combined with other sodium‑containing therapies.

Patients with known hypersensitivity to sodium chloride, those with severe hypernatremia, uncontrolled heart failure, or severe renal impairment should not receive this product unless a healthcare professional determines that the benefits outweigh the risks.